The primary limitations identified included the absence of a list of excluded studies and justification, as well as a written or registered protocol for the included studies, a lack of detailed funding sources, an assessment of risk of bias, and a discussion regarding the heterogeneity observed
As a GLP-1 receptor agonist, semaglutide mimics a natural hormone in your body that regulates appetite, blood sugar, and digestion
Low levels have been linked to chronic pain syndromes
If you're managing other health conditions or taking other medications, talk to your doctor before starting a GLP-1 through any platform
10.1016/j.neuropharm.2019.05.018 56 LauA.VilleneuveN
This is particularly relevant for semaglutide, given the possibility of GLP-1 analogs in milk, raising infant health concerns